Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu
© Borgis - Nowa Stomatologia 1/2019, s. 20-26 | DOI: 10.25121/NS.2019.24.1.20
*Marta Ziętek, Urszula Kaczmarek
Oral hygiene and periodontal status in children and adolescents with Down syndrome
Stan higieny jamy ustnej i przyzębia u dzieci i młodzieży z zespołem Downa
Department of Conservative and Paediatric Dentistry, Wroclaw Medical University
Head of Department: Professor Urszula Kaczmarek, PhD, MD
Streszczenie
Wstęp. Zespół Downa, najczęściej spotykana aberracja chromosomowa, jest zespołem wad wrodzonych spowodowany obecnością dodatkowego chromosomu 21. Cechom dysmorficznym i wadom układowym w całym organizmie towarzyszy różnego stopnia niepełnosprawność umysłowa. Wady zgryzu, dysproporcja między rozwojem narządu żucia a językiem, a także nieprawidłowy tor oddechowy, gorsza higiena oraz słabsze samooczyszczanie (zmniejszona sekrecja śliny) implikują rozwój chorób przyzębia u osób z zespołem Downa.
Cel. Określenie stanu higieny jamy ustnej oraz stanu przyzębia u dzieci i młodzieży z zespołem Downa w odniesieniu do osób zdrowych.
Materiał i metody. Badaniem objęto 150 osób obojga płci w wieku od 5 do 21 lat, w tym 75 chorych z zespołem Downa (grupa badawcza) i 75 ogólnie zdrowych (grupa kontrolna). U wszystkich badanych przeprowadzono badanie kliniczne jamy ustnej oceniające poziom higieny (uproszczony wskaźniki OHI-S i aproksymalny wskaźnik płytki – API) i stan przyzębia (wskaźnik dziąsłowy GI wg Löe i Sillness’a i zmodyfikowany wskaźnik krwawienia z kieszonki dziąsłowej – mSBI).
Wyniki. Frekwencja zapaleń przyzębia u chorych z zespołem Downa wynosiła 100%. Chorych w porównaniu ze zdrowymi cechował gorszy stan przyzębia – zarówno wartości wskaźnika GI, jak i mSBI były istotnie wyższe (0,90 ± 0,56 vs. 0,39 ± 0,53; 70,99% ± 27,65% vs. 26,69% ± 34,94%; p < 0,001). Zanotowano istotnie wyższą niż u zdrowych wartość wskaźnika OHI-S 1,68 ± 0,68 (vs. 1,32 ± 0,76) oraz wskaźnika API (86,66% ± 17,78%; vs. 66,34% ± 34,33%; p < 0,001).
Wnioski. U chorych z zespołem Downa w porównaniu ze zdrowymi stwierdzono istotnie gorszy stan higieny jamy ustnej i gorszy kliniczny stan przyzębia.
Summary
Background. Down syndrome, the most common chromosomal aberration, is a congenital disorder caused by having an extra 21st chromosome.
Dysmorphic features and characteristic systemic defects are accompanied by mental disability of varying degree. Malocclusions, disproportion between the development of masticatory system and the tongue, abnormal respiratory tract, poor oral hygiene, and reduced salivary secretion contribute to the development of periodontal diseases in patients with Down syndrome.
Aim. The aim of the study was to assess oral hygiene and gingival health status in children and adolescents with Down syndrome compared to generally healthy subjects.
Materials and methods. The study included 150 subjects of both genders, aged between 5 and 21 years. The research group comprised of children and adolescents with Down syndrome (n = 75) and a control group with generally healthy individuals (n = 75).
Oral hygiene status was assessed using the oral Hygiene Index -Simplified (OHI-S) and the Aproximal Aproximal Plaque Index (API). Periodontal status was assessed using the Gingival Index (GI) and the Sulcus Bleeding Index (SBI).
Results. The prevalence of periodontitis among patients with Down syndrome reached 100%. GI and SBI values were significantly higher in Down syndrome group compared to control group (0.90 ± 0.56 vs . 0.39 ± 0.53; 70.99% ± 27.65% vs 26.69% ± 34.94%, respectively; p < 0.001). OHI-S and API values were also significantly higher in Down syndrome patients compared to healthy individuals (1.68 ± 0.68 vs 1.32 ± 0.76, p < 0.01; 86.66% ± 17.78 vs 66.34% ± 34.33, p < 0.001).
Conclusions. Patients with Down syndrome had significantly poorer oral hygiene and worse periodontal health status compared to healthy individuals.



Introduction
Down syndrome (DNS) is the most common autosomal chromosome abnormality in humans, covering a spectrum of characteristic traits. In 1959, DNS was found by Lejeune to be caused by the presence of an extra copy of chromosome 21 (1).
Chromosome 21 is the smallest human chromosome. It is classified as belonging to the G group of chromosomes responsible for the somatic development of reproductive organs, pelvis, heart, epicanthic folds, iris, lens, paranasal sinuses, phalanges and metacarpus, palmar and plantar dermatoglyphics, as well as muscle tone, cartilage and tendon elasticity, proportion between limbs and the trunk, and cranial proportions. The chromosome also determines the auricular shape, quality and quantity of hair, size of teeth, thickness of neurocranial bones, and intelligence and intellectual development (2, 3). The presence of an additional copy of chromosome 21 (or its long arms) causes metabolic disorders, internal organ defects, tissue dimorphism, and characteristic phenotypic features with varying degrees of mental retardation (3-7).
Oral cavity abnormalities such as malocclusion and disproportion in growth between the masticatory system and the tongue – as well as abnormal breathing patterns, poorer hygiene due to impaired manual skills and lower self-cleaning ability (reduced secretion of saliva) – imply the development of caries and periodontal diseases in patients with Down syndrome (8).
In addition to topical factors, an important role in the development of periodontal diseases is attributed to generalized factors including impaired circulation leading to tissue hypoxia, reduced immunity, and propensity to infections, as well as systemic endocrine dysfunction. The first symptoms of periodontal diseases occur as early as between 6 and 15 years of age. The disorders may take the form of marginal gingivitis, acute or subacute necrotizing gingivitis, advanced periodontitis, gingival recessions as well as vertical and horizontal bone atrophy. A factor predisposing to the development of periodontitis is the presence of specific bacterial flora including Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, forming the so-called “red complex” (9-14).
Aim
The aim of the study was to determine the oral hygiene and periodontal status in children and adolescents with Down syndrome compared to healthy individuals.
Material and methods
A total of 150 subjects of both sexes (66 boys and 84 girls) aged between 5 and 21 years were selected for the study. The study group comprised children and adolescents with Down syndrome (n = 75), pupils of the Special School and Educational Centre No. 8 and 9, and the Special School and Educational Centre No. 10 in Wroclaw. The control group consisted of generally healthy children and adolescents (n = 75), age- and gender-matched to the study group, receiving dental treatment at Stomatologiczne Centrum Transferu Technologii Sp. z o.o., NZOZ Akademicka Poliklinika Stomatologiczna (University Dental Polyclinic) in Wroclaw.
The clinical oral examination evaluating the level of oral hygiene and periodontal status was carried out at the University Dental Polyclinic under artificial light, using a standard mouth mirror and a WHO-621 probe. The results of the examination were recorded in a specially prepared study sheet. The parents/carers were requested to fill in a questionnaire containing questions about the hygiene habits of the study patients. Questions asked in the survey included whether the child brushes his/her teeth, whether he/she performs this activity on his/her own or with the help of parents, when the child last brushed his/her teeth, whether the child cleans his/her teeth with a manual or electric toothbrush, and whether he/she uses dental floss, interdental brushes, toothpicks, and chewing gum.
Oral hygiene was evaluated using the Oral Hygiene Index-Simplified (OHI-S) of Greene and Vermillion, and the Approximal Plaque Index (API). The periodontal status was assessed using the Gingival Index (GI) of Löe and Sillness, and the modified Sulcus Bleeding Index (mSBI).
The results were analyzed statisically using the chi-square test, Pearson correlation coefficient and analysis of variance. The level of significance was p ≤ 0.05.
The study was approved by the Bioethics Committee at Wroclaw Medical University (approval no. KB – 71/2014).
Results
The prevalence of periodontitis in patients with Down syndrome was 100% and was thus 14.7% higher than in the healthy controls (100.0 vs. 85.3%; p < 0.001) (fig. 1).
Fig. 1. Frequency of periodontitis
The DNS patients had a poorer periodontal status compared to the healthy controls, as evidenced by significantly higher GI and mSBI values (p < 0.001). However, even though the GI level was approximately 3 times higher in the DNS patients than in healthy controls (0.90 ± 0.56 vs. 0.39 ± 0.53), the values obtained in both groups were in the range of 0.1-1.0, indicating mild gingivitis.
The mSBI value, which was equal to 70.99% ± 27.65 in the DNS patients, indicates severe generalized gingivitis, while the value of the index in the healthy subjects (26.69% ± 34.94) suggests mild gingivitis (tab. 1).
Tab. 1. Periodontal status
  Study group Control group Significance of differences
Indices x ± SD x ± SD 
mSBI (%)70.9 ± 27.6526.69 ± 34.94p < 0.001
GI0.90 ± 0.560.39 ± 0.53p < 0.001
Oral hygiene was worse in the DNS patients than in the healthy individuals, too. The mean OHI-S score was 1.68 ± 0.68 including the Debris Index (DI-S) of 1.58 ± 0.65 and the Calculus Index (CI-S) of 0.10 ± 0.14. The values of the Debris Index (DI-S) were found to be significantly higher (p < 0.01) in the DNS patients compared to the healthy controls, contributing to significantly higher values of the Oral Hygiene Index (OHI-S). There were no significant differences between the values of the Calculus Index (CI-S).

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1

24

Wybieram
  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2

59

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3

119

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
Piśmiennictwo
1. Prasher VP: Comparison of physical and psychiatric status in individuals with translocation and trisomy 21 Down syndrome. Downs Syndr Res Pract 1995; 3(1): 9-13.
2. Sustrova M, Sarikova V: Down’s syndrome-the impact of increased expression of genes of the 21st chromosome on the functions of immunity and nervous systems. Bratisl Lek Listy 1997; 98(4): 221-228.
3. Sadowska L, Mysłek-Prucnal M, Choińska AM, Mazur A: Diagnostyka i terapia dzieci z zespołem Downa w świetle badań własnych i przeglądu literatury przedmiotu. Przegl Med Uniw Rzesz 2009; 1: 8-30.
4. Opitz JM, Gilbert-Barness EF: Reflections of the pathogenesis of Down syndrome. Am Med Genet Supp 1990; 7: 38-51.
5. Coe DA, Matson JL, Russell DW et al.: Behavior problems of children with Down syndrome and life events. J Autism Dev Disord 1999; 29(2): 149-156.
6. Hattori M, Fujiyama A, Taylor TD et al.: The DNA sequence of human chromosome 21. Nature 2000; 405: 311-319.
7. Moraes MEL, Bastos MS, Santos LR et al.: Dental age in patients with Down syndrome. Braz Oral Res 2007; 21(3): 259-264.
8. Azfar M, Khan I, Iqbal N et al.: Oral health of individuals with Down syndrome in Karachi, Pakistan. J Pak Dent Assoc 2018; 27(4): 190-194.
9. Hanookai D: Herpesviruses and periodothopathic bacteria in trisomy 21. J Periodontol 2000; 71: 376-384.
10. Sakellari D, Belibasakis G, Chadjipadelis T et al.: Supragingival and subgingival microbiota of adult patients with Down’s syndrome. Changes after periodontal treatment. Oral Microbiol Immunol 2001; 16(6): 376-382.
11. Sakellari D, Arapostathis KN, Konstantinidis A: Periodontal conditions and subgingival microflora in Down syndrome patients. J Clin Periodontol 2005; 6: 684-690.
12. Yoshihara T, Morinushi T, Kinyo S, Yamasaki Y: Effect of periodic preventive care on the progression of periodontal disease in young adults with Down’s syndrome. J Clin Periodontol 2005; 32(6): 556-560.
13. Martinez-Martinez RE, Loyola-Rodriguez JP, Bonilla-Garro SE et al.: Characterization of periodontal biofilm in Down syndrome patients: a comparative study. J Clin Pediatr Dent 2013; 37(3): 289-295.
14. Ahmed N, Parthasarathy H, Arshad M et al.: Assessment of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in Down’s syndrome subjects and systemically healthy subjects: A comparative clinical trial. J Indian Soc Periodontol 2014; 18(6): 728-733.
15. Reuland-Bosma W, van Dijk J: Periodontal disease in Down syndrome: a review. J Clin Periodontol 1986; 13(1): 64-73.
16. Lopez-Perez R, Borges-Yáñez SA, Jimènez-García G, Maupomè G: Oral hygiene, gingivitis and periodontitis in persons with Down syndrome. Spec Care Dentist 2002; 22(6): 214-220.
17. Morgan J: Why is periodontal disease more prevalent and more severe in people with Down syndrome? Spec Care Dentist 2007;27(5): 196-201.
18. Al-Sufyani GA, Al-Maweri SA, Al-Ghashm AA, Al-Soneidar WA: Oral hygiene and gingival health status of children with Down syndrome in Yemen: A cross-sectional study. J Int Soc Prev Community Dent 2014; 4(2): 82-86.
19. Rahul VK, Mathew C, Jose S et al.: Oral manifestation in mentally challenged children. J Int Oral Health 2015; 7(2): 37-41.
20. Khocht A, Yaskell T, Janal M et al.: Subgingival microbiota in adult Down syndrome periodontitis. J Periodont Res 2012; 47: 500-507.
21. Page RC, Offenbacher S, Schroeder HE et al.: Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997;14: 216-248.
22. Carrada CF, Scalioni F, Cesar D et al.: Salivary periodontopathic bacteria in children and adolescents with Down syndrome. PLoS One 2016; 11(10): e0162988.
23. Barkin RM, Weston WL, Humbert JR, Maire F: Phagocytic function in Down syndrome. I. Chemotaxis. J Ment Defic Res 1980; 24: 243-249.
24. Gemmell E, Marshall RI, Seymour GJ: Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997; 14: 112-143.
25. Emingil G, Atilla G, Baskesen A, Berdeli A: Gingival crevicular fluid EMAPII, MIP-1alpha and MIP1beta levels of patients with periodontal disease. J Clin Periodontol 2005; 32(8): 880885.
26. Ram G, Chinen J: Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 2011; 164: 9-16.
27. Cavalcante LB, Tanaka MH, Pires JR et al.: Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis. J Periodontol 2012; 83: 926-935.
28. Ferreira R, Michel RC, Greghi SL et al.: Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review. PLoS One 2016; 11(6): e0158339.
29. Cutress TW: Periodontal disease and oral hygiene in trisomy 21. Arch Oral Biol 1971; 16(11): 1345-1355.
30. Orner G: Periodontal disease among children with Down’s syndrome and their siblings. J Dent Res 1976; 55: 778-782.
31. Buckley S, Sacks B: Oral health problems and quality of life. Downs Syndr Res Prac 2007; 12(1): 17.
32. Grollmus ZCN, Morales Chavez MC, Donat FJS: Periodontal disease associated to systemic genetic disorders. Med Oral Patol Oral Cir Bucal 2007; 12: E211-215.
33. Zigmond M, Stabholz A, Shapira J et al.: The outcome of a preventive dental care programme on the prevelence of localized aggressive periodontitis in Down’s syndrome individuals. J Intell Dis Res 2006; 50(7): 492-500.
34. Shapiro S, Gedalia L, Hofman A, Miller M: Periodontal disease and blood citrate levels in patients with trisomy 21. J Dent Res 1969; 48: 1231-1233.
35. Loureiro ACA, Oliveira Costa F, da Costa JE: The impact of periodontal disease on the quality of life of individuals with Down syndrome. Downs Syndr Res Pract 2007; 12(1): 50-54.
36. Allison PJ, Lawrence HP: A paired comparison of dental care in Canadians with Down syndrome and their siblings without Down syndrome. Community Dent Oral Epidemiol 2004; 32(2): 99-106.
37. Oredugda FA: Oral health condition and treatment needs of a group of Nigerian individuals with Down syndrome. Downs Syndr Res Pract 2007; 12(1): 72-77.
38. Kumar S, Sharma J, Duraiswamy P, Kulkarni S: Determinants for oral hygiene and periodontal status amoung mentally disabled children and adolescents. J Indian Soc Pedod Prevent Dent 2009; 3(27): 151-157.
39. Teitelbaum AP, Pochapski MT, Jansen JL et al.: Evaluation of the mechanical and chemical control of dental biofilm in patients with Down syndrome. Community Dent Oral Epidemiol 2009; 37: 463-467.
40. Al Habashneh R, Al-Jundi S, Khader Y, Nofel N: Oral health status and reasons for not attending dental care among 12- to 16-year-old children with Down syndrome in special needs centres in Jordan. Int J Dent Hyg 2012; 10: 259-264.
41. Bradley C, McAlister T: The oral health of children with Down syndrome in Ireland. Spec Care Dentist 2004; 24(2): 55-60.
42. De Jongh A, Van Houtem C, Van Der Schoof M et al.: Oral health status, treatment needs, and obstacles to dental care among noninstitutionalized children with severe mental disabilities in The Netherlands. Spec Care Dentist 2008; 28(3): 111-115.
43. Pels E: Ocena stanu higieny jamy ustnej i stanu przyzębia u dzieci z zespołem Downa. Przegl Stom Wieku Rozw 1999; 25(1): 14-17.
otrzymano: 2018-11-28
zaakceptowano do druku: 2019-02-01

Adres do korespondencji:
*Marta Ziętek
Katedra i Zakład Stomatologii Zachowawczej i Dziecięcej Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
ul. Krakowska 26, 50-425 Wrocław
tel.: +48 (71) 784-03-62
agata.z@vp.pl

Nowa Stomatologia 1/2019
Strona internetowa czasopisma Nowa Stomatologia